Age differences in primary prevention implantable cardioverter-defibrillator use in U.S. individuals

Vivian Tsai1, Mary K Goldstein, Henry H Hsia

  • 1School of Medicine, Stanford University Stanford, California 94305, USA. vtsai@stanford.edu

Insights

Potentially inappropriate use of implantable cardioverter-defibrillators (ICDs) was less common in older adults. Physicians appropriately deferred ICD implantation in many older patients with high comorbid burden.

Area of Science:

  • Cardiology
  • Medical Device Research
  • Geriatric Medicine

Background:

  • Implantable cardioverter-defibrillators (ICDs) are crucial for preventing sudden cardiac death.
  • Assessing appropriate ICD use in older populations is essential due to age-related changes and comorbidities.

Purpose of the Study:

  • To estimate the potentially inappropriate use of ICDs in older U.S. adults.
  • To analyze the relationship between age, risk stratification, and ICD implantation.

Main Methods:

  • Retrospective study utilizing the National Cardiovascular Data ICD Registry.
  • Included 44,805 individuals receiving ICDs for primary prevention (2006-2008).
  • Risk stratification used the Multicenter Automatic Defibrillator Implantation (MADIT) II system.

Main Results:

  • 67% of ICD recipients were aged 65+, with 51% aged 75+.
  • Potentially inappropriate ICD use was 10% in those aged 75+, compared to 40% in those <65.
  • Age's association with nonarrhythmic death risk attenuated after adjusting for comorbidities.

Conclusions:

  • Potentially inappropriate ICD use is less prevalent in older Americans compared to younger groups.
  • Physicians appear to conservatively select older adults for ICDs, deferring those with high comorbidity.
  • Nearly a quarter of all individuals may have received ICDs inappropriately based on mortality risk.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...